Beers criteria

From WikiMD's WELLNESSPEDIA

What are Beers criteria?[edit]

Beers criteria define medications that generally should be avoided in ambulatory elderly patients, doses or frequencies of administration that should not be exceeded, and medications that should be avoided in older persons known to have any of several common conditions.

History[edit]

The criteria were originally developed using a formal consensus process for combining reviews of the evidence with expert input.

Inappropriate use of medications[edit]

The criteria for inappropriate use address commonly used categories of medications such as sedative-hypnotics, antidepressants, antipsychotics, antihypertensives, nonsteroidal anti-inflammatory agents, oral hypoglycemics, analgesics, dementia treatments, platelet inhibitors, histamine-2 blockers, antibiotics, decongestants, iron supplements, muscle relaxants, gastrointestinal antispasmodics, and antiemetics.

Guide for clinical practice[edit]

  • The criteria were intended to guide clinical practice, but also to inform quality assurance review and health services research.
  • Most would agree that prescriptions for medications deemed inappropriate according to Beers criteria represent poor quality care.
  • Unfortunately, harm does not only occur from receipt of these inappropriately prescribed medications.
  • In one comprehensive national study of medication-related emergency department visits for elderly patients, most problems involved common and important medications not considered inappropriate according to the Beers criteria—principally, oral anticoagulants (e.g., warfarin), antidiabetic agents (e.g., insulin), and antiplatelet agents (aspirin and clopidogrel).

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.